Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-05-15T03:13:23.964Z Has data issue: false hasContentIssue false
  • English
  • Français

Application of the multi-domain relevant outcome measure for Alzheimer’s disease in Chinese population

Published online by Cambridge University Press:  19 July 2021

Chunbo Li
Chunbo Li*
Affiliation:
Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China Institute of Psychology and Behavioral Science, Shanghai Jiao Tong University, Shanghai, China Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), Chinese Academy of Science, Shanghai, China
*
Email: licb@smhc.org.cn
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
International Psychogeriatrics , Volume 33 , Special Issue 11: Issue Theme: Advances in Assessment and Diagnosis of Dementia , November 2021 , pp. 1123 - 1124
Copyright
© International Psychogeriatric Association 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Carnero Pardo, C., Lopez Alcalde, S., Espinosa Garcia, M. and Sanchez Magro, I. (2017). Validation of the Spanish-language version of the Relevant Outcome Scale for Alzheimer’s disease. [Multicenter Study Validation Study]. Neurologia, 32 (7), 417–423. doi: 10.1016/j.nrl.2015.12.007 CrossRefGoogle Scholar
Holthoff, V. A., et al. (2011). Validation of the relevant outcome scale for Alzheimer’s disease: a novel multidomain assessment for daily medical practice. Alzheimer’s Research & Therapy, 3 (5), 27. doi: 10.1186/alzrt89 CrossRefGoogle ScholarPubMed
Jia, J., et al. (2016). Diagnosis and treatment of dementia in neurology outpatient departments of general hospitals in China. [Research Support, Non-U.S. Gov’t]. Alzheimers Dement, 12 (4), 446–453. doi: 10.1016/j.jalz.2015.06.1892 CrossRefGoogle Scholar
Monahan, P. O., et al. (2012). Practical clinical tool to monitor dementia symptoms: the HABC-Monitor. [Research Support, N.I.H., Extramural Validation Study]. Clinical Interventions in Aging, 7, 143–157. doi: 10.2147/CIA.S30663 CrossRefGoogle Scholar
Mori, T., et al. (2018). ABC dementia scale: a quick assessment tool for determining Alzheimer’s disease severity. Dementia and Geriatric Cognitive Disorders Extra, 8 (1), 85–97. doi: 10.1159/000486956 CrossRefGoogle ScholarPubMed
Robert, P., Ferris, S., Gauthier, S., Ihl, R., Winblad, B. and Tennigkeit, F. (2010). Review of Alzheimer’s disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? Alzheimer's Research & Therapy, 2 (4), 24. doi: 10.1186/alzrt48 CrossRefGoogle Scholar
Shader, R. I., Harmatz, J. S. and Salzman, C. (1974). A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment—Geriatric (SCAG). [Comparative Study]. Journal of the American Geriatrics Society, 22 (3), 107–113. doi: 10.1111/j.1532-5415.1974.tb01521.x CrossRefGoogle Scholar
Zhang, S., Qi, J., Yang, Q. and Guo, Q. (2021). Validation of the Chinese version of the relevant outcome scale for Alzheimer’s disease (CROSA). International Psychogeriatrics, 33, 1193–1205. doi: 10.1017/S1041610221000247 CrossRefGoogle Scholar